You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic inflammatory demyelinating polyradiculoneuropathy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Guillain-Barré Syndrome Trial in Vila Nova de Gaia (Inpatient Rehabilitation, Inspiratory muscle training)

Not yet recruiting
  • Guillain-Barré Syndrome
  • Inpatient Rehabilitation
  • Inspiratory muscle training
  • Vila Nova de Gaia, Portugal
    Centro de Reabilitação do Norte
Jul 15, 2022

Age-Related Frailty Trial in Santa Monica (Therapeutic Plasma Exchange (TPE))

Enrolling by invitation
  • Age-Related Frailty
  • Therapeutic Plasma Exchange (TPE)
  • Santa Monica, California
    Neurological Associates - The Interventional Group
Apr 11, 2022

Gammanorm® in Autoimmune Diseases

Terminated
  • Autoimmune Diseases
  • Paris, France
  • +2 more
Mar 9, 2021

Relapsing Remitting Multiple Sclerosis, Progressive Multiple Sclerosis, Controls Trial in Montpellier (Blood withdrawal, MRI,

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +3 more
  • Blood withdrawal
  • +3 more
  • Montpellier, France
    CHU Montpellier
Dec 1, 2020

Small Fiber Neuropathy, Idiopathic Peripheral Neuropathy Trial in Boston (Intravenous immunoglobulin, 0.9% Sodium Chloride)

Active, not recruiting
  • Small Fiber Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Intravenous immunoglobulin
  • 0.9% Sodium Chloride
  • Boston, Massachusetts
    Beth Israel Deaconness Medical Center
Apr 16, 2021

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Autoimmune Diseases, Clarkson Syndrome Trial in Paris (IVIg)

Unknown status
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  • +3 more
  • Paris, France
    Grooupe Hospitalier Pitié Salpetrière
Jun 1, 2018

Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating

Completed
  • CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
  • CMT (Charcot Marie Tooth Disease)
  • cervical MRI
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Mar 8, 2018

Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

Recruiting
  • Multiple Sclerosis
  • 18F-florbetaben PET/CT
  • Pavia, PV, Italy
    ICS Maugeri SpA SB IRCCS
Mar 23, 2023

Neurological Autoimmune Diseases Trial in Mainz (Apheresis therapy by Octo Nova Technology (DIAMED, Cologne, Germany))

Completed
  • Neurological Autoimmune Diseases
  • Apheresis therapy by Octo Nova Technology (DIAMED, Cologne, Germany)
  • Mainz, Rheinland-Pfalz, Germany
    UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
Feb 14, 2021

Lipid Mediators in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • Samples
  • Pozzilli, Isernia, Italy
    IRCCS Neuromed
Nov 22, 2022

Ultrasonography and Electrophysiology in GBS

Not yet recruiting
  • Guillain-Barre Syndrome
  • nerve ultrasonography
  • (no location specified)
Jun 5, 2022

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in

Completed
Has Results
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • IgPro20
  • Birmingham, Alabama
  • +32 more
Sep 6, 2018

Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination Trial (Tysabri Injectable Product, Placebo)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome of Demyelination
  • Tysabri Injectable Product
  • Placebo
  • London, United Kingdom
    Royal London Hospital
Jan 25, 2023

Multiple Sclerosis, Pelvic Floor Disorders, Urinary Incontinence Trial in Gaziantep (breathing exercises, osteopathic manual

Recruiting
  • Multiple Sclerosis
  • +4 more
  • breathing exercises
  • osteopathic manual therapy techniques
  • Gaziantep, Turkey
    Tuba Maden
Jul 31, 2023

Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine

Not yet recruiting
  • Demyelinating Diseases
  • +4 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
  • Cladribine Subcutaneous Injection
  • 0.9% Chloride Injection Sodium
  • Warsaw, Mazowieckie, Poland
    Institute of Psychiatry and Neurology
Jul 26, 2023

Pain, Chronic Trial in Assiut (Ozone, Convtrol group)

Not yet recruiting
  • Pain, Chronic
  • Assiut, Egypt
    Emad Zarief Kamel Said
Jan 4, 2022

Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy, Inflammatory Polyneuropathy Trial in Arlington Heights (Panzyga IVIG,

Not yet recruiting
  • Small Fiber Neuropathy
  • +3 more
  • Panzyga IVIG
  • Placebo
  • Arlington Heights, Illinois
    Northwest Community Healthcare
Aug 22, 2022

COVID-19 Trial in Karachi (SARS-CoV-2 antibody based IVIG therapy)

Completed
  • COVID-19
  • SARS-CoV-2 antibody based IVIG therapy
  • Karachi, Sindh, Pakistan
    Dow University of Health Sciences
Mar 21, 2021

Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Mar 16, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine 10 mg oral tablet
  • Porto Alegre, RS, Brazil
    Pontifical Catholic University of Rio Grande do Sul
Jun 5, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Birmingham (Spinal Manipulation, Sham Spinal Manipulation)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Spinal Manipulation
  • Sham Spinal Manipulation
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jun 30, 2022

Relapsing Multiple Sclerosis Trial in Japan, Russian Federation (Ofatumumab, Matching of ofatumumab)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Toon-city, Ehime, Japan
  • +13 more
Apr 27, 2022

Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +2 more
  • ABT-199 (Main Cohort)
  • ABT-199 (Safety Expansion Cohort)
  • Tucson, Arizona
  • +47 more
Nov 19, 2021

End Stage Renal Disease on Dialysis Trial in Zrifin (Colchicine 0.5 MG, Placebo)

Recruiting
  • End Stage Renal Disease on Dialysis
  • Colchicine 0.5 MG
  • Placebo
  • Zrifin, Israel
    Asaf ha Rofeh, MC
Dec 28, 2022